We are live on ! Find out more
Triatomic Management

Triatomic Management Portfolio holdings

AUM $3.39M Turnover 77.78%
1-Year Est. Return 3.35%
This Fund
S&P 500
This Quarter Est. Return
-19.01%
1 Year Est. Return
-3.35%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.39M
AUM Growth
-$50.2M
Cap. Flow
-$3.62M
Cap. Flow %
-106.88%
Top 10 Hldgs %
100%
Holding
27
New
2
Increased
1
Reduced
3
Closed
19
Avg Time Held Equity + Options
1.5 years
Top 10 Avg Time Held Equity + Options
0 years
Top 20 Avg Time Held Equity + Options
0.1 years
Avg Time Held Equity only
1.5 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.8 years

Top Buys

Rank Stock Value
1
W icon
Wayfair
W
+$891K
2
MRNA icon
Moderna
MRNA
+$664K
3
AGNT icon
AGNT Inc
AGNT
+$223K

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$1.14M
2
BEKE icon
KE Holdings
BEKE
+$1.07M
3
META icon
Meta Platforms (Facebook)
META
+$983K
4
BABA icon
Alibaba
BABA
+$606K
5
IOT icon
Samsara
IOT
+$449K

Sector Composition

Rank Sector Weight
1 Consumer Staples 33.82%
2 Healthcare 31.11%
3 Consumer Discretionary 23.33%
4 Real Estate 11.72%
5 Miscellaneous 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GOTU icon
1
Gaotu Techedu
GOTU
$592M
$1.15M 33.82%
234,000
– –
2023 Q2
4 quarters
W icon
2
Wayfair
W
$15.5B
$791K 23.33%
+15,000
New +$891K
2024 Q2
0 quarters
MRNA icon
3
Moderna
MRNA
$80.9B
$623K 18.39%
+5,250
New +$664K
2024 Q2
0 quarters
AGNT icon
4
AGNT Inc
AGNT
$697M
$397K 11.72%
35,203
+20,400
+138% +$223K
2022 Q4
6 quarters
STLN icon
5
Starling Oncology
STLN
$704M
$369K 10.89%
802,965
-81,724
-9% -$69.8K
2021 Q4
10 quarters
CMAX icon
6
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$57.5K 1.7%
20,613
-18,505
-47% -$57.8K
2021 Q4
10 quarters
SNTI icon
7
Senti Biosciences Holdings
SNTI
$5.93M
$4.28K 0.13%
1,549
-29,504
-95% -$95.6K
2022 Q3
7 quarters
CMAXW icon
8
DELISTED
CareMax, Inc. Warrant
CMAXW
$917 0.03%
65,021
– –
2021 Q4
10 quarters
ACMR icon
9
CALL
ACM Research
ACMR
$3.42B
– –
-50,000
Closed -$1.46M –
ADPT icon
10
Adaptive Biotechnologies
ADPT
$3.9B
– –
-98,555
Closed -$316K –
AMD icon
11
CALL
Advanced Micro Devices
AMD
$829B
– –
-6,000
Closed -$1.08M –
AVGO icon
12
CALL
Broadcom
AVGO
$1.54T
– –
-50,000
Closed -$6.63M –
BABA icon
13
Alibaba
BABA
$253B
– –
-8,370
Closed -$606K –
BEKE icon
14
KE Holdings
BEKE
$18.9B
– –
-78,023
Closed -$1.07M –
C icon
15
PUT
Citigroup
C
$206B
– –
-50,000
Closed -$3.16M –
GOOGL icon
16
CALL
Alphabet (Google) Class A
GOOGL
$3.97T
– –
-50,000
Closed -$7.55M –
IOT icon
17
Samsara
IOT
$25.6B
– –
-11,877
Closed -$449K –
IWM icon
18
PUT
iShares Russell 2000 ETF
IWM
$79.4B
– –
-20,000
Closed -$4.21M –
KRE icon
19
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$3.55B
– –
-100,000
Closed -$5.03M –
META icon
20
Meta Platforms (Facebook)
META
$1.65T
– –
-2,025
Closed -$983K –
NIO icon
21
NIO
NIO
$8.29B
– –
-50,000
Closed -$225K –
PDD icon
22
Pinduoduo
PDD
$113B
– –
-9,795
Closed -$1.14M –
SNOW icon
23
CALL
Snowflake
SNOW
$111B
– –
-40,000
Closed -$6.46M –
SPY icon
24
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
– –
-10,000
Closed -$5.23M –
XLF icon
25
PUT
State Street Financial Select Sector SPDR ETF
XLF
$52.6B
– –
-100,000
Closed -$4.21M –

Similar funds

Triatomic Management's Q2 2024 Portfolio in Review

As of Q2 2024, Triatomic Management held 27 positions worth $3.39M, down 94% from $53.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Triatomic Management withdrew a net $3.62M in Q2 2024, closing 19 positions and reducing 3 holdings. Its most notable exit was Pinduoduo, an estimated $1.14M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 34% of assets, up from 2.9% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Triatomic Management opened a new position in Wayfair worth $791K.

  • Triatomic Management's largest Q2 2024 buy was Wayfair: 15,000 shares worth $791K.
  • Triatomic Management added most to AGNT Inc in Q2 2024, an estimated $223K increase.
  • Triatomic Management's biggest Q2 2024 reduction was Senti Biosciences Holdings, cutting an estimated $95.6K.
  • Triatomic Management fully exited Pinduoduo in Q2 2024, selling an estimated $1.14M.
  • Triatomic Management's ten largest holdings make up 100% of its $3.39M portfolio in Q2 2024.
  • Triatomic Management opened 2 new positions and closed 19 in Q2 2024.
  • Triatomic Management's portfolio value fell 94% quarter-over-quarter to $3.39M.

Based on Triatomic Management's 13F filing for Q2 2024, filed 14 Aug 2024.